These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Aspirin, chance, and results in relation to blood pressure. López-Rodríguez I; Rodríguez-Ledo MP Hypertension; 2004 Apr; 43(4):e22-3; author reply e22-3. PubMed ID: 14967832 [No Abstract] [Full Text] [Related]
7. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Weyrich AS; Skalabrin EJ; Kraiss LW Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042 [TBL] [Abstract][Full Text] [Related]
8. ESPRIT study design and outcomes--a critical appraisal. Einhäupl K Curr Med Res Opin; 2007 Feb; 23(2):271-3. PubMed ID: 17288680 [TBL] [Abstract][Full Text] [Related]
10. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients? Rouhl RP; Lodder J Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236 [TBL] [Abstract][Full Text] [Related]
11. Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone. Delanty N J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):832. PubMed ID: 10617388 [No Abstract] [Full Text] [Related]
12. Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone. Jolobe OM J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):832. PubMed ID: 10617389 [No Abstract] [Full Text] [Related]
13. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)]. Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408 [No Abstract] [Full Text] [Related]
14. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient? Halkes PH; Algra A Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645 [TBL] [Abstract][Full Text] [Related]
15. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management. Lutsep HL J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244 [TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease? Beckman JA Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S12-6. PubMed ID: 19530155 [TBL] [Abstract][Full Text] [Related]
20. Dipyridamole plus aspirin: the best regimen for stroke prevention after noncardioembolic focal cerebral ischemia. Jonas S; Grieco G Cerebrovasc Dis; 2006; 22(1):1-3. PubMed ID: 16567930 [No Abstract] [Full Text] [Related] [Next] [New Search]